Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats
- 1 March 1978
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 29 (3) , 373-395
- https://doi.org/10.1016/0021-9150(78)90084-9
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Clofibrate retardation of naturally-occurring arteriosclerosis in repeatedly-bred male and female ratsAtherosclerosis, 1978
- Gallbladder Disease as a Side Effect of Drugs Influencing Lipid Metabolism Experience in the Coronary Drug ProjectNew England Journal of Medicine, 1977
- Effects of P-Chlorophenoxyisobutyrate (CPIB) on Serum Insulin Levels, Insulin Sensitivity and Adipose Tissue Cyclic AMP ConcentrationEndocrinology, 1973
- The Treatment of Cerebrovascular Disease With ClofibrateStroke, 1973
- Clofibrate in coronary heart disease. Effect on morbidity and mortalityPublished by American Medical Association (AMA) ,1972
- Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.BMJ, 1971
- Ischaemic Heart Disease: A Secondary Prevention Trial Using ClofibrateBMJ, 1971
- Trial of Clofibrate in the Treatment of Ischaemic Heart Disease: FIVE-YEAR STUDY BY A GROUP OF PHYSICIANS OF THE NEWCASTLE UPON TYNE REGIONBMJ, 1971
- Long-term treatment of hyperlipidemic patients with clofibratePublished by American Medical Association (AMA) ,1971
- Serum creatine phosphokinase activity following isoproterenol-induced myocardial infarction in male and female rats with and without arteriosclerosisAmerican Heart Journal, 1970